107
Views
45
CrossRef citations to date
0
Altmetric
Miscellaneous

Block copolymeric biotransport carriers as versatile vehicles for drug delivery

, , , &
Pages 583-602 | Published online: 23 Feb 2005

Bibliography

  • ALAKHOV VY, KABANOV AV: Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opiri. Irivestig. Drugs (1998) 7(9):1453–1474.
  • •Detailed review that describes major properties of block copolymers as drug formulation components.
  • KABANOV AV, NAZAROVA IR, ASTAFIEVA IV et al: Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules (1995) 28:2303–2321.
  • NAGARAJAN R, GANESH K: Synthesis and antibacterial evaluation of N-alkyl vancomycins. Macromolecules (1989) 22:4312–4321.
  • SCHMOLKA IR: Physical basis for poloxamer interactions. j Am. Oil Chem. Soc. (1977) 54:110–126.
  • ••Describes fundamental basis forsupramolecular assembly of block copolymers.
  • LINSE P: Micellization of poly(ethylene oxide) poly(propylene oxide) block copolymers in aqueous solutions. Macromolecules (1993) 26:4437–4449.
  • HUNGER PN, SCHELTENS JMHM, DAYTON TA: Molecular modelling of micelle formations and solibilization in block copolymer micelle. Macromolecules (1993) 26:5030–5052.
  • •Important work that describes possibility of modelling of block copolymer colloids.
  • ASTASEVA I, ZHONG XF, ESENBERG A: Critical micellization phenomena in block polyelectrolites. Macromolecules (1993) 26:7339–7342.
  • MAIMSTEN M, LINDMAN B: Self-assembly in aqueous block copolymer solutions. Macromolecules (1992) 25:5440–5456.
  • GROOT RD, WARREN PB: Dissipative particle dynamics: bringing the gap between atomistic and mesoscopic simulation. Chem. Phys. (1997) 107:4423–4435.
  • BASF Performance Chemicals. BASF Co., Parsipany, NJ, USA (1991).
  • YAMAMOTO Y, NAGASAKY Y, KATO M, KATAOKA K: Colloidal stability and drug incorporation aspects of micellar-like PLA- PEG nanoparticles. Colloids and Surfaces B: Bioiriterfaces (1999) 16:135–147.
  • ZHANG X, JACKSON JK, BURT HM: Preparation and characterization of the micelle-forming polymeric drugs. Int. Pharmacol (1996) 85:85–98.
  • YOKOYAMA M, KWON GS, OKANO T, SAKURAI Y, NAITO M, KATAOKA K: Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycofl-poly(aspartic acid) block copolymer. Cancer Res. (1990) 50:1693–1700.
  • KWON G, NAITO M, YOKAYAMA M, OKANO T, SAKURAI Y, KATAOKA K: Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. I Contr. Release (1997) 48:195–202.
  • LA SB, OKANO T, KATAOKA K: Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. j Pharm. Sci. (1996) 85:85–90.
  • KIM SW, SHIN IG, LEE YM, CHO CS, SUNG YK: Block copolymer micelles as vehicles for drug delivery. j Contr. Release (1998) 51:13–18.
  • ALLEN C, MAYSINGER D, EISENBERG A: Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Biocorg. Chem. (1998) 9:564–572.
  • JEONG YI, CHEON JB, KIM SH: Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method. Arch. Pharm. Res. (1998) 4:418–422.
  • RAMASWAMY M, ZHANG X, BURT HM, WASAN KM: Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. Pharm. Li. (1997) 86:460–464.
  • KATAYOSE S, KATAOKA K: Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer. I Pharm. Li. (1998) 87:160–164.
  • NGUYEN HN, LEMIEUX P, VINOGRADOV S et al: Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. (2000) 7:126–138.
  • ENDERBY CJM, LEYTE JC: The distribution of water around poly(ethyleneoxide): a neutron diffraction study. J. Phys. Chem. (1994) 98:6568–6578.
  • UNTER RJ: Foundations of Colloid Science. Oxford University Press, New York, USA (1991) 1:38.
  • KWON GS, OKANO T: Synthetic studies of vitamin D analogs. XXII. Synthesis and antiproliferation activity of putative metabolites of 1 alpha, 25-dihydroxy-22-oxavitamin D3. advan. Drug Delivery Rev (1996) 21:107–116.
  • KABANOV AV, ALAKHOV VY: New approaches to targeting of bioactive compounds. j Contr. Release (1994) 28:15–
  • KABANOV AV, NAZAROVA IR, ASTAFIEVA IV: Micelle formation and solubilisation of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules (1995) 28:2303–2311.
  • EISENBERG A: Thermodynamic vs. kinetic aspects in the formation and morphological transitions of crew-cut aggregates produced by self-assembly of polystyrene-b-poly(acrylic acid) block copolymers in dilute solution. Macromolecules (1999) 32:2239–2249.
  • ••One of the first papers devoted to non-spherical micelles formed by block copolymers.
  • ALEXANDRIDIS E HATTON TA: Colloids Surf. A Phisicochem. Eng. Asp. (1995) 96:1.
  • NAGARAJAN R: Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles. Curr. Opin Colloid Interf. Sci. (1996) 1:391–398.
  • ZHANG L, EISENBERG A: Compliance measurements of confined polystyrene solutions by atomic force microscopy. Science (1995) 268:1728–1732.
  • ZHANG L, YU K, EISENBERG A: Ion-induced morphological changes in 'crew-cut' aggregates of amphiphilic block copolymers. Science (1996) 272:1777–1782.
  • ZHANG L, BARLOW, EISENBERG A: Wetting behavior of homopolymer films on chemically similar block copolymer surfaces. Macromolecules (1995) 28:6055–6063.
  • DESJARDINS A, EISENBERG A: Aggregation and critical micelle concentrations of polystyrene-b-poly(sodium acrylate) and polystyrene-b-poly(acrylic acid) micelles in organic media. Macromolecules (1991) 24:5779–5784.
  • JOHNSON DL, POLIKANDRITOU-LAMBROS M, MARTONEN TB: Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols. I Drug Deify. Targ. Therapeutic Agents (1996) 3:9–16.
  • BRONICH TK, SOLOMATIN SV, YAROSLAVOV AA, EISENBERG A, KABANOV VA, KABANOV AV: Steric stabilization of negatively charged liposomes by cationic graft copolymer. Langmuir (2000) 11:4877–4881.
  • GAO Z, EISENBERG A: A model of micellization for block copolymer in solutions. Macromolecules (1993) 26:7353–7362.
  • SCHLILLEN K, BROWN W, JOHNSON RM: Micellar sphere-to rod transition in an aqueous triblock copolymer system. A dynamic light scattering study of translational and rotational diffusion. Macromolecules (1994) 27:4825–4833.
  • WILHELM M, ZHAO C-L, WANG Y et al.: Poly(sterene-ethylene oxide). Block copolymer micelle formation in water: a fluorescence probe study. Macromolecules (1991) 28:2303–2312.
  • NAGARAJAN R: Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-POP-PEO) block copolymers. Colloid Surf (1999) 16:55–72.
  • NAGARAJAN R, WANG CC: Theory of surfactant aggregation in water/ethylene glycol mixed solvents. Langmuir (2000) 12:5242–5251.
  • ••Describes the major considerations ofsolubilisation theory that can be used to predict drug behavior in block copolymer based formulations.
  • NAGARAJAN R, GANESH K: Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles. Macromolecules (1989) 22:489–499.
  • NAGARAJAN R, GANESH K: Solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymers. I Colloid Interf Sci. (1996) 184:489–496.
  • SOKOL RJ, JOHNSON KE, KARRER FM, NARKEWICZ MR, SMITH D, KAM I: Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet (1991) 338:212–214.
  • HANDE KR, KROZELY MG, GRECO FA, HAINS WORTH JD, JOHNSON DH: Bioavailability of low-dose oral etoposide.j OM. Omni (1993) 2:374–377.
  • MYERS JS, KEARNEY K: Emergency. Chemotherapy-induced hypersensitivity reaction. Am. j Nurs. (2000) 4:53–54.
  • KWON GS, KATAOKA K: Block copolymer micelles as long-circulating drug vehicles. Adv. Drug. Delivery Rev (1995) 16:295–301.
  • YOKOYAMA M, SUGIYAMA T, OKANO T et al.: Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm. Res. (1993) 10:895–901.
  • KWON GS, NAITO M, YOKOYAMA M etal.: Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res. (1995) 12:192–198.
  • RAPOPORT N: Stabilization and activation of Pluronic micelles for tumor- targeted drug delivery. Colloids Surf (1999) 16:93–112.
  • KWON GS, KATAOKA K: Block copolymer micelles as long-circulating drug vehicles. Adv. Drug. Delivery Rev (1995) 16:295–299.
  • BURT HM, ZHANG X, TOLIEKIS P, EMBREE L, HUNTER W: Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf (1999) 16:161–172.
  • WATSON JC, SUTANTO-WARD E, OSAKU M, WEINSTEIN JK, BABB JS, SIGURDSON ER: Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats. Surgery (1999) 126:358–363.
  • ALAKHOV V, KLINSKI E, LI S et al: Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf (1999) 16:113–134.
  • LIU M, VLADIMIROV N, FRÉCHETV JMJ: A new approach to hyperbranched polymers by ring-opening polymerization of an AB monomer: 4-(2-hydroxyethyl)-caprolactone. Macromolecules (1999) 32:6881–6884.
  • SMITH DK, DIED ERICH F: Comparisonof the capacity of beta-cyclodextrin derivatives and cyclophanes to shuttle cholesterol between cells and serum lipoproteins. Chem. Eur. j (1998) 4:1353–1363.
  • GRUBBS RB, HAWKER CJ, DAO J, FRECHET JMJ: The melt viscosity of dendritic poly(benzyl ether) macromolecules. Int. Ed. Engl. (1997) 36:270–281.
  • GAUTHIER M, TICHAGWA L, DOWNEY JS, GAO S: Arborescent graft copolymers: highly branched macromolecules with a core-shell morphology. Macromolecules (1996) 29:519–527.
  • TANAKA T: Viscoelastic properties of miscible poly(methyl methacrylate)/ poly(styrene-co-acrylonitrile) blends in the molten state. Macromolecules (1999) 32:8560–8565.
  • TAKASHI I, KINTSU K, YAMAMOTO H: NMR study of the solution structures of the inclusion complexes of -cyclodextrin with (+)-catechin and 0-epicatechin. Phys. Chem. (1999) 103:8992–8997.
  • TPANEK M, PROCHAZKA K: Fluorometric studies of the polyelectrolyte shell of block copolymer micelles in aqueous media. Langmuir (1999) 15:8800–8806.
  • ZHANG Q, TSUI OKC, DU B, ZHANG F, TANG T, HE T: Observation of inverted phases in poly(styrene-b-butadiene-b-styrene) triblock copolymer by solvent-induced order-disorder phase transition. Macromolecules (2000) 33:9561–9567.
  • WOOLEY KL: Location of fluorotryptophan sequestered in an amphiphilic nanoparticle by rotational-echo double-resonance NMR. Chem. Eur. (1997) 3:1397–1399.
  • THURMOND KB, HUANG H, CLARK CG, KOWALEWSKI T, WOOLEY KL: Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPO-PEO) block copolymers. Colloids Surf (1999) 16:45–54.
  • MORTENSEN K, PERDERSEN S: Shear-induced transition of originally undisturbed lamellar phase to vesicle phase. Macromoleclules (1993) 26:805–811.
  • JHONSTON TP, PUNJABI MA, FROELICH CJ: Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm. Res. (1992) 9:425–431.
  • CAMMAS S, SUZUKI K, SONE Y, SAKURAI Y, KATAOKA K, OKANO T: Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. j Control. Release (1997) 48:157–164.
  • CHUNG JE, YOKOYAMA M, SUZUKI K, AOYAGI T, SAKURAI Y, OKANO T: Reversibly thermo-responsive alkyl-terminated poly(N-isopropylacriylamide) core-shell micellar structures. Colloids Surf B: Biointerf (1997) 9:37–48.
  • CHUNG JE, YOKOYAMA M, AOYAGI T, SAKURAI Y, OKANO T: Effect of molecular architecture of hydropbobically modified polylsopropylacrylamide on the formation of thremoresponsive core-shell micellar drug carriers. j Contr. Release (1998) 53:119–130.
  • KOHORI F, SAKAI K, AOYAGI T, YOKAYAMA M, SAKURAI Y, OKANO T: Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-D,L-lactide). Conti: Release (1998) 55:87–98.
  • TAKEI YG, AOKI T, SANUI K, OGATA N, OKANO T, SAKURAI Y: Temperature-responsive bioconjugates. 2. Molecular design for temperature-modulated bioseparations. Bioconjug. Chem. (1993) 4:341–346.
  • BERMAN J, HOWARD RJ: Combinatorial drug discovery: concepts. In: Combinatorial Chemistry and Molecular Diversity in Drug Discovery Gordon E, Kerwin J (Eds.), John Wiley & Sons, New York, USA (1998):447–452.
  • KATRITZKY AR, LOBANOV VS, KARELSON M: QSPR: the correlation and quantitative prediction of chemical and physical properties from structure. Chem. Soc. Rev (1995) 24:279–284.
  • BICERANO J: Prediction of polymer properties. Marcel Dekker, New York, USA (1993).
  • BROCCHINI S, JAMES K, TANGPASUTHADOL V, KOHN J: Structure-property correlation in a combinatorial library of degradable biomaterials. j Biomed. Mater. Res. (1998) 42:66–75.
  • •One of the major papers on combinatorial material science.
  • BROCCHINI S, JAMES K, TANGPASUTHADOL V, KOHN J: A combinatorial approach for polymer design. J Am. Chem. Soc. (1997) 119:4553–4554.
  • REYNOLDS CH: Designing diverse andfocused combinatorial libraries of synthetic polymers. j Comb. Chem. (1999) 1:297–306.
  • HUIBERS PDT, LOBANOV VS, KATRIZKY AR, SHAH DO, KARELSON M: Prediction of critical micelle concentration using a quantitative structure-property relationship approach. 1. Nonionic surfactants. Langmuir (1996) 12:1462–1470.
  • SUN H: COMPASS: An ab Milk force-field optimized for condensed-phase applications - overview with details on alkane and benzene compounds. j Phys. Chem. (1998) 102:7338–7364.
  • FRAAIJE JG, VAN VLIMMEREN BA, MAURITS NM et al.: The dynamic mean-field density functional method and its application to the mesoscopic dynamics of quenched block copolymer melts. j Chem. Phys. (1997) 106:4260–4269.
  • ALTEVOGT P, EVERS OA, FRAAIJE JG, MAURITS NM, VAN VLIMMEREN BA: The MesoDyn project: software for mesoscale chemical engineering. j Mal Struct. Theochem. (1999) 463:139–143.
  • WU SE, HOPKINS WK, SHEU YE: TPGS as a drug Carrier and adsorption enhancer. In: Proceedings of the International Symposium on the Controlled Release of Bioactive Materials. Controlled Release Society, Deerfield, USA (1996):23.
  • LI Y, KWON GS: Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugates. Colloid Surfaces B: Biointerfaces. (1999) 16:217–226.
  • REMPP E MERILL EW: Polymer Synthesis. Hilthig & Wept', Heidelberg, Germany (1986).
  • FOSTERS, ANTONIETTI M: Amphiphilic block copolymers in structure- controlled nanomaterial hybrids. Adv. Mater (1998) 10:195–217.
  • Amphiphilic Block Copolymers: Self-Assembly and Applications. Alexandridis E Lineman B (Eds.), Elsevier, Amsterdam (1997).
  • VINOGRADOV SV, BRONICH TK, KABANOV A: Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. (1998) 9:805–812.
  • KWON GS, KATAOKA K: Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deify. Rev (1995) 16:295–309.
  • BROMBERG L: Novel family of thermogelling materials via C-C bonding between poly(acrylic acid) and poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide). I Phys. Chem. (1998) 102:1956–1963.
  • BROMBERG L, TEMCHENKO M: Self-assembly in aqueous solutions of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)-b-poly(vinyl alcohol). Langmuir (1999) 15:8633–8639.
  • JEONG B, BEA YH, KIM SW: Biodegradable thermosensitive micelles of PEG-PLGA-PEG triblock copolymers. Colloids and Surfaces B: Biointerfaces (1999) 16:185–193.
  • HILLMYER MA, BATES FS: Synthesis and characterization of model polyalkane-poly(ethylene oxide) block copolymers. Macromolecules (1996) 29:6994–7002.
  • GORDON EM, GALLOP MA, PATEL DV: Strategy and tactics in combinatorial organic synthesis. Applications to drug discovery. Arr. Chem. Res. (1996) 29:144–154.
  • DOVE A: Drug screening - beyond the bottleneck. Nature Biotech. (1999) 17:859–863.
  • ALAKHOV VY, MOSKALEVA EY., BATRAKOVA EV et al.: Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconjug. Chem. (1996) 7:209–215.
  • BATRAKOVA EV, DORODNYCH TY, KLINSKII EY et al.: Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br Cancer (1996) 74:1545–1553.
  • VENNE A, LI S, MANDEVILLE R et al:Hypersensitizing effect of Pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. (1996) 56:3626–3632.
  • BATRAKOVA EV, LI S, MILLER DW, KABANOV AV: Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. (1999) 16:1366–1372.
  • BATRAKOVA EV, HAN HY, ALAKHOV VYU, MILLER DW, KABANOV AV: Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. (1998) 15:850–855.
  • BATRAKOVA EV, HAN HY, MILLER DW, KABANOV AV: Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. (1998) 15:1525–1532.
  • MILLER DW, BATRAKOVA EV, KABANOV AV: Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharm. Res. (1999) 16:396–401.
  • LEMIEUX P, GUERIN N, PARADIS G et al.: A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther. (2000) 7:986–991.
  • •The first paper that describes application of non-ionic block copolymers as biological response modifying agents for delivery of plasmid DNA.
  • GOLDSTEIN LJ, GOTTESMAN MM, PASTAN I: Expression of the MDR1 gene in human cancers. Cancer Treat. Res. (1991) 57:101–112.
  • GOLDSTEIN LJ, GOTTESMAN MM, PASTAN I: Multidrug resistance in human cancer. Crit. Rev arca Hematol. (1992) 12:243–256.
  • LEPAGE P, GROSS P: Structural and functional aspects of P-glycoproteins and related transport proteins. Curr. Opin Nephrol. Hypertens. (1993) 2:735–745.
  • SADEQUE AJ, WANDEL C, HE H, SHAH S, WOOD AJ: Increased drug delivery to the brain by P-glycoprotein inhibition. Clin. Pharmacol. Ther. (2000) 68:231–237.
  • SCHWARZ UI, GRAMATTE T, KRAPPWEIS J, OERTEL R, KIRCH W: P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int. j Clin. Pharmacol. Ther. (2000) 38:161–167.
  • LOTSCH J, TEGEDER I, ANGST MS, GEISSLINGER G: Antinociceptive effects of morphine-6-glucuronide in homozygous MDRla P-glycoprotein knockout and in wild type mice in the hotplate test. Life Li. (2000) 66:2393–2403.
  • HABGOOD MD, BEGLEY DJ, ABBOTT NJ: Determinants of passive drug entry into the central nervous system. Cell Mol. Neurobiol. (2000) 20:231–253.
  • KABANOV AV, BATRAKOVA EV, MELIK-NUBAROV NS et al.: A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. I Contr. Release (1992) 22:141–156.
  • BATRAKOVA EV, MILLER DW, LI S, ALAKHOV VYU, KABANOV AV, ELMQUIST WF: Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. _PET (2001) 296 (In Press).
  • BANERJEE SK, JAGANNATH C, HUNTER RL, DASGUPTA A: Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. Life Sci. (2000) 67(16):2011–2016.
  • CHANG T, BENET LZ, HEBERT MF: The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. (1996) 59(3):297–303.
  • BUCKINGHAM LE, BALASUBRAMANIAN M, SAFA AR et al.: Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int. I Cancer (1996) 65(1):74–79.
  • JAGANNATH C, WELLS A, MSHVILDADZE M et al: Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL- 1605 copolymer. Life ScL (1999) 64(19):1733–1738.
  • EVERS R, KOOL M, SMITH AJ, VAN DEEMTER L, DE HAAS M, BORST P: Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br j Cancer (2000) 83(3):366–374
  • WOLFF JA, MALONE RW, WILLIAMS P, CHONG W, ACSADI G, JANI A, FELGNER P: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465–1468.
  • FELGNER P: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465–1468.
  • TOKUI M, TAKEI I, TASHIRO F et al: Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. Biochem. Biophys. Res. Commun. (1997) 233:527–531.
  • TRIPATHY SK, SVENSSON EC, BLACK HB et al: Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl Acad. Sci. USA (1996) 93:10876–10880.
  • LATHI KG, VALE PR, LOSORDO DW et al.: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results. Ariesth. Arialg. (2001) 92(1):19–25.
  • LAHAM RJ, CHRONOS NA, PIKE Met al.: Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study. j Am. Coll. Cardiol (2000) 36(7):2132–2139.
  • ROLLAND AP, MUMPER RJ: Plasmid delivery to muscle: recent advances in polymer delivery systems. Adv. Drug Deify. Rev (1998) 30:151–117.
  • MUMPER RJ, DUGUID JG, ANWER K, BARRON MK, NITTA H, ROLLAND AP: PVP as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. (1996) 13:701–709.
  • ZHOU S, MURPHY JE, DWARKI VJ: Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther. (1998) 5:665–670.
  • Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Washington, The Pharmaceutical Press, London (1994).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.